How has Jazz Pharmaceuticals's research and development expense changed year-over-year?

Jazz Pharmaceuticals's research and development expense increased by 8.5% year-over-year, from $180.7M to $196M.

What is the long-term trend for Jazz Pharmaceuticals's research and development expense?

Over 4 years (2021 to 2025), Jazz Pharmaceuticals's research and development expense has grown at a 11.5% compound annual growth rate (CAGR), from $505.75M to $782.78M.

Jazz Pharmaceuticals JAZZ Research and development expense

Research and development expense at other companies

Johnson & JohnsonJNJ

$3.53B+9.4%

AmgenAMGN

——

BiogenBIIB

——

Neurocrine BiosciencesNBIX

——

Eli LillyLLY

——

Gilead SciencesGILD

——

Other financials

Income statement

See full

Revenue$1.1B+19.1%

Operating income$336.6M+702%

Net income$293.1M+417%

EPS (diluted)$4.43+391%

Balance sheet

See full

Cash & equivalents$667.5M-64.1%

Total debt$5.4B-0.1%

Total equity$4.5B+8.6%

Total assets$11.9B+2.8%

Cash flow

See full

Operating cash flow$408.2M-5.0%

CapEx$19.7M+41.7%

Free cash flow$388.5M-6.6%

Valuation

See full

Market cap$14.11B+54.4%

Enterprise value$18.85B+47.7%

P/S3.2×+0.9×

Profitability

See full

Operating margin-11.9%-28.1pp

Net margin-8.9%-20.5pp

FCF margin28.6%-8.6pp

Returns & leverage

See full

Return on equity-9.1%-21.2pp

Debt / equity1.2×-0.1×

Current ratio2×-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Jazz Pharmaceuticals's research and development expense?: Jazz Pharmaceuticals (JAZZ) reported research and development expense of $196M in Q1 2026.
How has Jazz Pharmaceuticals's research and development expense changed year-over-year?: Jazz Pharmaceuticals's research and development expense increased by 8.5% year-over-year, from $180.7M to $196M.
What is the long-term trend for Jazz Pharmaceuticals's research and development expense?: Over 4 years (2021 to 2025), Jazz Pharmaceuticals's research and development expense has grown at a 11.5% compound annual growth rate (CAGR), from $505.75M to $782.78M.